Prolia 60mg Injection

Product Description

Prolia 60mg Injection (Denosumab)

Prolia 60mg Injection contains Denosumab as its active ingredient. It is used to treat osteoporosis, a condition that weakens bones, making them more prone to fractures. Additionally, it is prescribed to prevent bone complications in patients with multiple myeloma and bone metastases from certain cancers.

Denosumab works by inhibiting RANK ligand, a protein involved in bone breakdown. Clinical studies have shown that it significantly increases bone density and reduces the risk of fractures, especially in postmenopausal women and individuals experiencing cancer-related bone loss. Patients with moderate renal impairment may require close monitoring of their kidney function during treatment.

Precautions & Contraindications

• Allergic Reactions: Not recommended for individuals with known hypersensitivity to Denosumab or its components.
• Calcium & Vitamin D: Adequate supplementation is necessary during treatment.
• Pediatric Use: Not approved for individuals under 18 years, as its safety and effectiveness in this group have not been established.
• Hypoparathyroidism: Should be used with caution in individuals with low parathyroid hormone levels.

Consult your doctor before using Prolia 60mg Injection to ensure safe and appropriate treatment.